Observational study of lenalidomide in patients with mantle cell lymphoma who relapsed/progressed after or were refractory/intolerant to ibrutinib (MCL-004)

BACKGROUND: The observational MCL-004 study evaluated outcomes in patients with relapsed/refractory mantle cell lymphoma who received lenalidomide-based therapy after ibrutinib failure or intolerance. METHODS: The primary endpoint was investigator-assessed overall response rate based on the 2007 Int...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Michael, Schuster, Stephen J., Phillips, Tycel, Lossos, Izidore S., Goy, Andre, Rule, Simon, Hamadani, Mehdi, Ghosh, Nilanjan, Reeder, Craig B., Barnett, Evelyn, Bravo, Marie-Laure Casadebaig, Martin, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668956/
https://www.ncbi.nlm.nih.gov/pubmed/29096668
http://dx.doi.org/10.1186/s13045-017-0537-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668956/
https://www.ncbi.nlm.nih.gov/pubmed/29096668
http://dx.doi.org/10.1186/s13045-017-0537-5

Ejemplares similares